The success of copyright’s blockbuster initially drove a surge for pharma, but recent shifts present a complicated picture for those considering a stake. Lower-cost versions are reducing revenue, and continued https://tessiaqi000034.theblogfairy.com/39998687/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-bet